journal article·2026-05

Lesion‐Localized Lubricating Microspheres Loaded with Highly Permeable Spermidine‐Derived Carbon Quantum Dots Attenuate Post‐Traumatic Ankle Osteoarthritis

Tiancong Ma, Yinuo Zhang, Jinyang Lyu, Shihao Zhang, Lang Qin, Shengxuan Cao, Jiaqi Shi, Maimaitirexiati Helili, Xiang Geng, Chao Zhang, Jiazhang Huang, Jia Jiang, Xu Wang, Yulin Li, Li Chen, Xin Ma

Advanced Functional Materials· Volume 36· Issue 37
Publisher page

Abstract

ABSTRACT Post‐traumatic ankle osteoarthritis (PTOA) lacks effective conservative therapeutic strategies and requires the simultaneous mitigation of chronic inflammation, lubrication dysfunction, and progressive cartilage degeneration. In this study, spermidine‐derived carbon quantum dots (Spd‐CDs, SCD) were synthesized, and self‐healing lubricating microspheres were fabricated from aldehyde hyaluronic acid (AHA) and 2,2′‐diselanediyldiethanamine dihydrochloride (Sel). These microspheres (AHA+Sel, ASM) possess aldehyde‐functionalized surfaces that enable preferential localization to damaged cartilage, and exhibit intrinsic self‐healing capability through the synergistic effects of dynamic Schiff base bonds and diselenide bonds. Highly permeable SCD was subsequently encapsulated into ASM to construct a sustained‐release system (ASM@SCD). In vitro, SCD exerted pronounced anti‐inflammatory and antioxidative effects, inhibited chondrocyte ferroptosis, and restored dysregulated cartilage extracellular matrix metabolism. Mechanistically, bulk RNA‐sequencing combined with targeted lipidomics revealed that SCD enhanced ferroptosis resistance by promoting ACSL3‐dependent incorporation of monounsaturated fatty acids into plasma membranes, displacing polyunsaturated fatty acid‐containing phospholipids, and thereby reducing susceptibility to lipid peroxidation. In vivo, ASM@SCD treatment suppressed early cartilage degeneration and aberrant subchondral bone remodeling, improved joint function, preserved normal gait patterns, and significantly attenuated PTOA progression. Collectively, ASM@SCD represents a promising non‐surgical therapeutic strategy for PTOA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Carbon and Quantum Dots Applications · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics Huashan Hospital Fudan University Shanghai China

Key Laboratory For Ultrafine Materials of the Ministry of Education Engineering Research Centre For Biomedical Materials of the Ministry of Education East China University of Science and Technology Shanghai China

Department of Orthopedics Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.4085/1062‐6050‐447‐1710.4085/1062‐6050‐447‐17 ↗
2. 10.4085/1062‐6050‐472‐1710.4085/1062‐6050‐472‐17 ↗
3. 10.1177/036354651142858110.1177/0363546511428581 ↗
4. 10.1177/036354650528181310.1177/0363546505281813 ↗
5. 10.1007/s00776‐003‐0732‐910.1007/s00776‐003‐0732‐9 ↗
6. 10.1186/s12951‐022‐01245‐810.1186/s12951‐022‐01245‐8 ↗
7. 10.3390/life1407082910.3390/life14070829 ↗
8. 10.1177/0363546523121749010.1177/03635465231217490 ↗
9. 10.1186/s12891‐022‐05164‐510.1186/s12891‐022‐05164‐5 ↗
10. 10.1038/s41565‐021‐01051‐710.1038/s41565‐021‐01051‐7 ↗
11. 10.1002/adma.20231324810.1002/adma.202313248 ↗
12. 10.1002/adhm.20230320610.1002/adhm.202303206 ↗
13. 10.1186/s12951‐022‐01681‐610.1186/s12951‐022‐01681‐6 ↗
14. 10.1002/advs.20230502310.1002/advs.202305023 ↗
15. 10.1126/science.aan278810.1126/science.aan2788 ↗
16. 10.1038/s41419‐020‐2710‐y10.1038/s41419‐020‐2710‐y ↗
17. 10.1016/j.freeradbiomed.2020.03.02910.1016/j.freeradbiomed.2020.03.029 ↗
18. 10.2147/ijn.S51893510.2147/ijn.S518935 ↗
19. 10.1021/acsami.2c1859810.1021/acsami.2c18598 ↗
20. 10.1021/acsnano.7b0102310.1021/acsnano.7b01023 ↗
21. 10.1080/17425247.2025.251343910.1080/17425247.2025.2513439 ↗
22. 10.1016/j.mtbio.2023.10059710.1016/j.mtbio.2023.100597 ↗
23. 10.1002/adma.20240594310.1002/adma.202405943 ↗
24. 10.1002/advs.20240034510.1002/advs.202400345 ↗
25. 10.1021/acsami.3c1720910.1021/acsami.3c17209 ↗
26. 10.1016/j.carbpol.2022.11916110.1016/j.carbpol.2022.119161 ↗
27. 10.1016/j.cej.2024.15373410.1016/j.cej.2024.153734 ↗
28. 10.1038/s41467‐024‐55785‐810.1038/s41467‐024‐55785‐8 ↗
29. 10.1016/j.chembiol.2018.11.01610.1016/j.chembiol.2018.11.016 ↗
30. 10.1186/s13045‐022‐01297‐110.1186/s13045‐022‐01297‐1 ↗
31. 10.1038/s41556‐023‐01136‐610.1038/s41556‐023‐01136‐6 ↗
32. 10.1002/ctd2.20010.1002/ctd2.200 ↗
33. 10.1038/s41556‐024‐01377‐z10.1038/s41556‐024‐01377‐z ↗
34. 10.1021/acs.analchem.5c0223310.1021/acs.analchem.5c02233 ↗
35. 10.1021/acsnano.3c0424110.1021/acsnano.3c04241 ↗
36. 10.1002/advs.20240247710.1002/advs.202402477 ↗
37. 10.1038/nrrheum.2010.21310.1038/nrrheum.2010.213 ↗
38. 10.1016/j.redox.2025.10366010.1016/j.redox.2025.103660 ↗
39. 10.1016/j.bioactmat.2024.06.00710.1016/j.bioactmat.2024.06.007 ↗
40. 10.1016/j.jare.2024.04.01210.1016/j.jare.2024.04.012 ↗
41. 10.1016/j.ymthe.2025.05.03710.1016/j.ymthe.2025.05.037 ↗
42. 10.1016/j.tem.2024.09.00310.1016/j.tem.2024.09.003 ↗
43. 10.1038/nchembio.223910.1038/nchembio.2239 ↗
44. 10.1038/s41586‐020‐2732‐810.1038/s41586‐020‐2732‐8 ↗
45. 10.1016/j.ejphar.2021.17439710.1016/j.ejphar.2021.174397 ↗
46. 10.1007/s11914‐014‐0192‐510.1007/s11914‐014‐0192‐5 ↗
47. 10.1016/j.bioactmat.2023.10.03210.1016/j.bioactmat.2023.10.032 ↗
48. 10.1186/s12951‐022‐01758‐210.1186/s12951‐022‐01758‐2 ↗
49. 10.1021/acs.langmuir.8b0244110.1021/acs.langmuir.8b02441 ↗
50. 10.1002/adma.20231255910.1002/adma.202312559 ↗